The largest database of trusted experimental protocols

Taqman rt pcr kit

Manufactured by Yeasen

The TaqMan RT-PCR Kit is a real-time reverse transcription-polymerase chain reaction (RT-PCR) system designed for the detection and quantification of RNA. The kit includes all the necessary components, including specific TaqMan probes and primers, to perform sensitive and accurate RNA detection and analysis.

Automatically generated - may contain errors

2 protocols using taqman rt pcr kit

1

SARS-CoV-2 Nanobody Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SARS-CoV-2 (strain IVCAS 6.7512) was provided by the National Virus Resource, Wuhan Institute of Virology, Chinese Academy of Sciences. All SARS-CoV-2 live virus-related experiments were approved by the Biosafety Committee Level 3 (ABSL-3) of Wuhan University. All experiments involving SARS-CoV-2 were performed in the BSL-3 and ABSL-3 facilities. Briefly, nanobodies were serially diluted in culture medium and 100 μL was mixed with 100 μL (1000 PFU) SARS-CoV-2 for 30 min. The mixture was then added to Vero E6 cells in 48-well plates and incubated for 24 h, after which TRIzol (Invitrogen) was added to inactivate SARS-CoV-2 viruses and extract RNA according to the manufacturer's instructions. First-strand cDNA was synthesized using the PrimeScript RT kit (TakaRa). A real-time quantitative PCR was used to detect the presence of SARS-CoV-2 viruses by the primers (Table 1). The relative number of SARS-CoV-2 viral genome copies was determined using a TaqMan RT-PCR Kit (Yeason). To accurately quantify the absolute number of SARS-CoV-2 genomes, a standard curve was prepared by measuring the SARS-CoV-2 N gene constructed in the pCMV-N plasmid. All SARS-CoV-2 genome copy numbers were normalized to GAPDH expression in the same cell.
+ Open protocol
+ Expand
2

Evaluating Antibody Protection Against SARS-CoV-2 in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
K18-hACE2 KI mice, which express hACE2 driven by the human epithelial cell cytokeratin-18 (K18) promoter, were purchased from Gempharmatech. All animal experiments were approved by the Animal Care and Use Committee of Wuhan University. For antibody prophylactic experiments, mice were grouped for injection of antibodies (10 mg/kg). At dpi 0, mice were inoculated intranasally with 250 PFU SARS-CoV-2. For antibody therapeutic effect, mice were inoculated with 250 PFU of SARS-CoV-2 by the intranasal route, and one day later, mice were injected with antibodies (20 mg/kg). Body weights were monitored daily, and the endpoint is at dpi 8 or when mice dead or when mice’s weight reached 80% of starting weight. Tissues were harvested for tissue homogenates and histology analysis. The H&E and immunofluorescence stain and imaging were carried by Wuhan Pinuofei Biological Technology company. The viral gene copies were detected by a TaqMan RT-PCR Kit (Yeason). To accurately quantify the absolute number of SARS-CoV-2 genomes, a standard curve was prepared by measuring the SARS-CoV-2 E and N gene plasmid.39 (link) All animal studies were approved by the Institutional Animal Care and Use Committee at Wuhan University (WP20220044).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!